147 related articles for article (PubMed ID: 15383705)
21. Dual modes of membrane binding direct pore formation by Streptolysin O.
Mozola CC; Caparon MG
Mol Microbiol; 2015 Sep; 97(6):1036-50. PubMed ID: 26059530
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol-dependent cytolysins.
Gilbert RJ
Adv Exp Med Biol; 2010; 677():56-66. PubMed ID: 20687480
[TBL] [Abstract][Full Text] [Related]
23. Cellular functions and X-ray structure of anthrolysin O, a cholesterol-dependent cytolysin secreted by Bacillus anthracis.
Bourdeau RW; Malito E; Chenal A; Bishop BL; Musch MW; Villereal ML; Chang EB; Mosser EM; Rest RF; Tang WJ
J Biol Chem; 2009 May; 284(21):14645-56. PubMed ID: 19307185
[TBL] [Abstract][Full Text] [Related]
24. Studies on the structure and mechanism of a bacterial protein toxin by analytical ultracentrifugation and small-angle neutron scattering.
Gilbert RJ; Heenan RK; Timmins PA; Gingles NA; Mitchell TJ; Rowe AJ; Rossjohn J; Parker MW; Andrew PW; Byron O
J Mol Biol; 1999 Nov; 293(5):1145-60. PubMed ID: 10547292
[TBL] [Abstract][Full Text] [Related]
25. Structure-based functional studies for the cellular recognition and cytolytic mechanism of pneumolysin from Streptococcus pneumoniae.
Park SA; Park YS; Bong SM; Lee KS
J Struct Biol; 2016 Feb; 193(2):132-40. PubMed ID: 26688057
[TBL] [Abstract][Full Text] [Related]
26. Specificity of streptolysin O in cytolysin-mediated translocation.
Meehl MA; Caparon MG
Mol Microbiol; 2004 Jun; 52(6):1665-76. PubMed ID: 15186416
[TBL] [Abstract][Full Text] [Related]
27. Streptolysin O: inhibition of the conformational change during membrane binding of the monomer prevents oligomerization and pore formation.
Abdel Ghani EM; Weis S; Walev I; Kehoe M; Bhakdi S; Palmer M
Biochemistry; 1999 Nov; 38(46):15204-11. PubMed ID: 10563803
[TBL] [Abstract][Full Text] [Related]
28. Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis.
LaChapelle S; Tweten RK; Hotze EM
J Biol Chem; 2009 May; 284(19):12719-26. PubMed ID: 19293153
[TBL] [Abstract][Full Text] [Related]
29. A cell membrane modification technique using domain 4 of intermedilysin for immunotherapy against cancer.
Nagamune H; Ohkura K; Umezu K; Shouji H; Kourai H
Anticancer Res; 2004; 24(5C):3367-72. PubMed ID: 15515433
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of cytotoxin protein suilysin from Streptococcus suis.
Xu L; Huang B; Du H; Zhang XC; Xu J; Li X; Rao Z
Protein Cell; 2010 Jan; 1(1):96-105. PubMed ID: 21204001
[TBL] [Abstract][Full Text] [Related]
31. Contribution of individual tryptophan residues to the structure and activity of theta-toxin (perfringolysin O), a cholesterol-binding cytolysin.
Sekino-Suzuki N; Nakamura M; Mitsui KI; Ohno-Iwashita Y
Eur J Biochem; 1996 Nov; 241(3):941-7. PubMed ID: 8944786
[TBL] [Abstract][Full Text] [Related]
32. LacR mutations are frequently observed in Streptococcus intermedius and are responsible for increased intermedilysin production and virulence.
Tomoyasu T; Imaki H; Masuda S; Okamoto A; Kim H; Waite RD; Whiley RA; Kikuchi K; Hiramatsu K; Tabata A; Nagamune H
Infect Immun; 2013 Sep; 81(9):3276-86. PubMed ID: 23798532
[TBL] [Abstract][Full Text] [Related]
33. Streptolysin O: the C-terminal, tryptophan-rich domain carries functional sites for both membrane binding and self-interaction but not for stable oligomerization.
Weis S; Palmer M
Biochim Biophys Acta; 2001 Feb; 1510(1-2):292-9. PubMed ID: 11342166
[TBL] [Abstract][Full Text] [Related]
34. Streptolysin O: a proposed model of allosteric interaction between a pore-forming protein and its target lipid bilayer.
Palmer M; Vulicevic I; Saweljew P; Valeva A; Kehoe M; Bhakdi S
Biochemistry; 1998 Feb; 37(8):2378-83. PubMed ID: 9485385
[TBL] [Abstract][Full Text] [Related]
35. Functional and phylogenetic characterization of Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis.
Gelber SE; Aguilar JL; Lewis KL; Ratner AJ
J Bacteriol; 2008 Jun; 190(11):3896-903. PubMed ID: 18390664
[TBL] [Abstract][Full Text] [Related]
36. Disentangling the roles of cholesterol and CD59 in intermedilysin pore formation.
Boyd CM; Parsons ES; Smith RA; Seddon JM; Ces O; Bubeck D
Sci Rep; 2016 Dec; 6():38446. PubMed ID: 27910935
[TBL] [Abstract][Full Text] [Related]
37. Cholesterol-dependent cytolysins: The outstanding questions.
Johnstone BA; Joseph R; Christie MP; Morton CJ; McGuiness C; Walsh JC; Böcking T; Tweten RK; Parker MW
IUBMB Life; 2022 Dec; 74(12):1169-1179. PubMed ID: 35836358
[TBL] [Abstract][Full Text] [Related]
38. The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae.
Rossjohn J; Gilbert RJ; Crane D; Morgan PJ; Mitchell TJ; Rowe AJ; Andrew PW; Paton JC; Tweten RK; Parker MW
J Mol Biol; 1998 Nov; 284(2):449-61. PubMed ID: 9813129
[TBL] [Abstract][Full Text] [Related]
39. Multiple Parameters Beyond Lipid Binding Affinity Drive Cytotoxicity of Cholesterol-Dependent Cytolysins.
Ray S; Thapa R; Keyel PA
Toxins (Basel); 2018 Dec; 11(1):. PubMed ID: 30577571
[TBL] [Abstract][Full Text] [Related]
40. Interaction of streptolysin-O with natural and artificial membranes.
Fehrenbach FJ; Eibl H
Z Naturforsch C Biosci; 1977; 32(1-2):101-9. PubMed ID: 139770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
